Top Markets
Coin of the day
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
株式のランク #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
株価
$25.61
最終同期: 2025-10-10
時価総額
$1.37B
変化(1日)
0.20%
変化(1年)
1.55%
US
取引 Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

カテゴリー

Harrow Health, Inc. 8.625% Senior Notes due 2026(HROWL)の発行済株式数
August 2026 時点の発行済株式数 0
Harrow Health, Inc. 8.625% Senior Notes due 2026 の最新の財務報告および株価によると、現在の発行済株式数は 0 です。August 2026 の終わりには、同社は 0 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Harrow Health, Inc. 8.625% Senior Notes due 2026(HROWL)の発行済株式数の履歴(2026 ~ 2026)
各年末時点の発行済株式数
発行済株式数 変化
提供された日付のデータは十分ではありません。
類似企業や競合他社の発行済株式数